Wednesday, March 29, 2023

Protecting Kids' Hearts | Bladder Cancer | Sleep Problems, Cancer Information Highlights, 03/29/2023

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Dexrazoxane Protects the Heart in Kids Being Treated for Cancer
A doppler echocardiogram measures blood flow in the heart.   Doxorubicin is used to treat many types of childhood cancer, but it can damage the heart. Giving dexrazoxane (Zinecard) before each dose greatly reduces a child's risk of treatment-related heart problems in adulthood.
Immunotherapy after Surgery Shows Benefits for Bladder Cancer
  Updated results from a large clinical trial confirm that, for some people with bladder cancer, receiving nivolumab (Opdivo) after surgery is an effective treatment.
Preventing Tumor Resistance to Targeted Therapy

Many cancers that respond to targeted therapy will become resistant to the drugs in time. Researchers have learned more about how this resistance happens and how it may be disrupted.

PDQ Updates
Sleep Disorders

Sleep problems are common in people with cancer. Learn more about sleep problems, their causes, and how they are treated.
 
Also of Interest
Childhood Bladder Cancer

Bladder cancer is very rare in children. Learn about the symptoms and risk factors for childhood bladder cancer and how it is diagnosed and treated.
Contact Us for Help

Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo

No comments:

Post a Comment